Maa: Irlanti
Kieli: englanti
Lähde: HPRA (Health Products Regulatory Authority)
PHTHALYLSULFATHIAZOLE STREPTOMYCIN SULFATE
Chanelle Pharmaceuticals Manufacturing Limited
QA07AA99
Tablets
Antibacterial
Bovine
1994-05-09
IRISH MEDICINES BOARD ACT 1995 ANIMAL REMEDIES REGULATIONS, 2005 (S.I. NO. 734 OF 2005) VPA: 10987/049/001 Case No: 7002142 The Irish Medicines Board in exercise of the powers conferred on it by Animal Remedies Regulations (S.I. No. 734 of 2005) hereby grants to: CHANELLE PHARMACEUTICALS MANUFACTURING LIMITED LOUGHREA, CO. GALWAY, IRELAND an authorisation, subject to the provisions of the said Regulations and the general conditions of the attached authorisation, in respect of the Veterinary Medicinal Product: CHANACIN PLUS TABLET The particulars of which are set out in Part 1 and Part 2 of the said Schedule. The authorisation is also subject to any special conditions as may be specified in the said Schedule. Signed on behalf of the Irish Medicines Board ________________ A person authorised in that behalf by the said Board. (NOTE: This authorisation replaces any previous authorisation in respect of this product which is now null and void.) IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 28/11/2006_ _CRN 7002142_ _page number: 1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Chanacin Plus Tablet 2 QUALITATIVE AND QUANTITATIVE COMPOSITION For a full list of excipients see section 6.1. 3 PHARMACEUTICAL FORM Tablet. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Calves 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of scour in calves mainly due to _Escherichia coli _and _Salmonella _spp. 4.3 CONTRAINDICATIONS Do not use in animals with known hypersensitivity to the active ingredients. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTION(S) FOR USE IN ANIMALS Discontinue treatment after 36-48 Lue koko asiakirja